These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24566294)

  • 1. Is the consistency more important than the ingredients for steroid treatment in eosinophilic esophagitis?
    Parrish DW; Sharma S; Kumar S
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):286-9. PubMed ID: 24566294
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined and Alternating Topical Steroids and Food Elimination Diet for the Treatment of Eosinophilic Esophagitis.
    Reed CC; Safta AM; Qasem S; Angie Almond M; Dellon ES; Jensen ET
    Dig Dis Sci; 2018 Sep; 63(9):2381-2388. PubMed ID: 29380175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Therapy With Elimination Diet and Corticosteroids Is Effective for Adults With Eosinophilic Esophagitis.
    Reed CC; Tappata M; Eluri S; Shaheen NJ; Dellon ES
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2800-2802. PubMed ID: 30885887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical glucocorticoid vs. diet therapy in eosinophilic esophagitis: the need for better treatment options.
    Imam T; Gupta SK
    Expert Rev Clin Immunol; 2016 Aug; 12(8):797-9. PubMed ID: 27206496
    [No Abstract]   [Full Text] [Related]  

  • 5. Eosinophilic esophagitis: treatment with oral viscous budesonide.
    Zur E
    Int J Pharm Compd; 2012; 16(4):288-93. PubMed ID: 23050387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achalasia-like Changes in Eosinophilic Esophagitis.
    Surdea-Blaga T; David L; Botan EC; Dumitrascu DL
    J Gastrointestin Liver Dis; 2019 Jun; 28():146. PubMed ID: 31204405
    [No Abstract]   [Full Text] [Related]  

  • 7. Diarrhea, Ascites, and Eosinophilia.
    Francis FF; Kulich SM; Hashash JG
    Gastroenterology; 2016 Apr; 150(4):e6-8. PubMed ID: 26930018
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenal Suppression in Children Treated With Oral Viscous Budesonide for Eosinophilic Esophagitis.
    Harel S; Hursh BE; Chan ES; Avinashi V; Panagiotopoulos C
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):190-3. PubMed ID: 25950088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in Practices of Compounding Budesonide for Eosinophilic Esophagitis.
    Joshi S; Rubenstein JH; Dellon ES; Worthing N; Stefanadis Z; Chang JW
    Am J Gastroenterol; 2021 Jun; 116(6):1336-1338. PubMed ID: 33538420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide oral suspension (Eohilia) for eosinophilic esophagitis.
    Med Lett Drugs Ther; 2024 Jun; 66(1704):93-95. PubMed ID: 38905533
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Features at Baseline Cannot Predict Symptom Response to Placebo in Patients With Eosinophilic Esophagitis.
    Hirano I; Dellon ES; Collins MH; Williams J; Lan L; Katzka DA
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2126-2128.e1. PubMed ID: 30502508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis.
    Dellon ES; Sheikh A; Speck O; Woodward K; Whitlow AB; Hores JM; Ivanovic M; Chau A; Woosley JT; Madanick RD; Orlando RC; Shaheen NJ
    Gastroenterology; 2012 Aug; 143(2):321-4.e1. PubMed ID: 22561055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function.
    Philla KQ; Min SB; Hefner JN; Howard RS; Reinhardt BJ; Nazareno LG; Vogt KS
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1101-6. PubMed ID: 26024243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of eosinophilic esophagitis with inhaled budesonide in a 7-year-old boy with concomitant persistent asthma: resolution of esophageal submucosal fibrosis and eosinophilic infiltration.
    Maples KM; Henderson SC; Graham M; Irani AM
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):572-4. PubMed ID: 18219842
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis.
    Molina-Infante J; Martin-Noguerol E; Alvarado-Arenas M; Porcel-Carreño SL; Jimenez-Timon S; Hernandez-Arbeiza FJ
    J Allergy Clin Immunol; 2012 Nov; 130(5):1200-2. PubMed ID: 22867695
    [No Abstract]   [Full Text] [Related]  

  • 16. In eosinophilic esophagitis, budesonide orodispersible tablets maintained remission at 48 wk.
    Srinivasan S; Sharma P
    Ann Intern Med; 2021 Apr; 174(4):JC44. PubMed ID: 33819066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
    Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
    Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
    Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
    Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental gastric eosinophils in patients with eosinophilic esophagitis: do they matter?
    Ammoury RF; Rosenman MB; Roettcher D; Gupta SK
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):723-6. PubMed ID: 20601904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.